OMMH
Price:
$0.0001
Market Cap:
$981.00
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monocl...[Read more]
Industry
Biotechnology
IPO Date
2022-12-30
Stock Exchange
OTC
Ticker
OMMH
According to Omnimmune Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of 319.44% compared to the average of -0.00 of the last 4 quarters.
The mean historical PE Ratio of Omnimmune Holdings, Inc. over the last ten years is -0.03. The current -0.01 PE Ratio has changed 2.96% with respect to the historical average. Over the past ten years (40 quarters), OMMH's PE Ratio was at its highest in in the May 2008 quarter at 0. The PE Ratio was at its lowest in in the February 2008 quarter at -0.05.
Average
-0.03
Median
-0.00
Minimum
-0.12
Maximum
-0.00
Discovering the peaks and valleys of Omnimmune Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 400.11%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -98.51%
Minimum Annual PE Ratio = -0.12
| Year | PE Ratio | Change |
|---|---|---|
| 2009 | -0.00 | 400.11% |
| 2008 | -0.00 | -98.51% |
| 2008 | -0.01 | -94.56% |
The current PE Ratio of Omnimmune Holdings, Inc. (OMMH) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.00
5-year avg
-0.03
10-year avg
-0.03
Omnimmune Holdings, Inc.’s PE Ratio is less than IMV Inc. (-0.00), less than eFFECTOR Therapeutics, Inc. (-0.00), less than ContraFect Corporation (-0.00), less than Adynxx, Inc. (-0.00), less than DMK Pharmaceuticals Corporation (-0.00), less than BioELife Corp. (-0.00), greater than Grupo International Inc. (-0.02), less than Adhera Therapeutics, Inc. (-0.00), less than Proteonomix, Inc. (-0.00), less than Minerva Surgical, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $117.00 | |
| -0.00 | $941.00 | |
| -0.00 | $1.07K | |
| -0.00 | $581.00 | |
| -0.00 | $1.01K | |
| -0.00 | $1.88K | |
| -0.02 | $1.04K | |
| -0.00 | $722.00 | |
| -0.00 | $791.00 | |
| -0.00 | $8.88K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omnimmune Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Omnimmune Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Omnimmune Holdings, Inc.'s PE Ratio?
How is the PE Ratio calculated for Omnimmune Holdings, Inc. (OMMH)?
What is the highest PE Ratio for Omnimmune Holdings, Inc. (OMMH)?
What is the 3-year average PE Ratio for Omnimmune Holdings, Inc. (OMMH)?
What is the 5-year average PE Ratio for Omnimmune Holdings, Inc. (OMMH)?
How does the current PE Ratio for Omnimmune Holdings, Inc. (OMMH) compare to its historical average?